 Gefitinib, functioning as an epidermal growth factor receptor tyrosine kinase inhibitor, improved symptoms related to non-small cell lung cancer and resulted in radiographic tumor regressions.This is an example of the efficacy of such an inhibitor.The process of inhibition shows how the cancer sustains.